ARTV
Price
$2.28
Change
-$0.09 (-3.80%)
Updated
Sep 17 closing price
Capitalization
55.69M
61 days until earnings call
TNFA
Price
$3.87
Change
-$0.08 (-2.03%)
Updated
Sep 17 closing price
Capitalization
7.06M
Interact to see
Advertisement

ARTV vs TNFA

Header iconARTV vs TNFA Comparison
Open Charts ARTV vs TNFABanner chart's image
Artiva Biotherapeutics
Price$2.28
Change-$0.09 (-3.80%)
Volume$107.79K
Capitalization55.69M
TNF Pharmaceuticals
Price$3.87
Change-$0.08 (-2.03%)
Volume$299.96K
Capitalization7.06M
ARTV vs TNFA Comparison Chart in %
Loading...
ARTV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARTV vs. TNFA commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTV is a Hold and TNFA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (ARTV: $2.28 vs. TNFA: $3.86)
Brand notoriety: ARTV and TNFA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARTV: 89% vs. TNFA: 0%
Market capitalization -- ARTV: $55.69M vs. TNFA: $7.06M
ARTV [@Biotechnology] is valued at $55.69M. TNFA’s [@Biotechnology] market capitalization is $7.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARTV’s FA Score shows that 1 FA rating(s) are green whileTNFA’s FA Score has 1 green FA rating(s).

  • ARTV’s FA Score: 1 green, 4 red.
  • TNFA’s FA Score: 1 green, 4 red.
According to our system of comparison, ARTV is a better buy in the long-term than TNFA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARTV’s TA Score shows that 3 TA indicator(s) are bullish while TNFA’s TA Score has 6 bullish TA indicator(s).

  • ARTV’s TA Score: 3 bullish, 7 bearish.
  • TNFA’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, TNFA is a better buy in the short-term than ARTV.

Price Growth

ARTV (@Biotechnology) experienced а -15.56% price change this week, while TNFA (@Biotechnology) price change was +6.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.28%. For the same industry, the average monthly price growth was +6.08%, and the average quarterly price growth was +34.58%.

Reported Earning Dates

ARTV is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+1.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARTV($55.7M) has a higher market cap than TNFA($7.06M). ARTV YTD gains are higher at: -77.381 vs. TNFA (-96.643). TNFA has higher annual earnings (EBITDA): -8.36M vs. ARTV (-79.07M). ARTV has more cash in the bank: 142M vs. TNFA (3.81M). TNFA has less debt than ARTV: TNFA (0) vs ARTV (13.2M). ARTV (0) and TNFA (0) have equivalent revenues.
ARTVTNFAARTV / TNFA
Capitalization55.7M7.06M790%
EBITDA-79.07M-8.36M946%
Gain YTD-77.381-96.64380%
P/E RatioN/AN/A-
Revenue00-
Total Cash142M3.81M3,724%
Total Debt13.2M0-
FUNDAMENTALS RATINGS
TNFA: Fundamental Ratings
TNFA
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARTVTNFA
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 23 days ago
84%
Bullish Trend 8 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ARTV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UNTY51.940.66
+1.30%
Unity Bancorp
BBUC34.910.43
+1.25%
Brookfield Business Corp
SOL1.89N/A
N/A
Emeren Group Ltd
SNOA4.10-0.10
-2.38%
Sonoma Pharmaceuticals Inc
PAAS35.34-0.87
-2.40%
Pan American Silver Corp

ARTV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARTV has been loosely correlated with ERAS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ARTV jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARTV
1D Price
Change %
ARTV100%
-3.80%
ERAS - ARTV
42%
Loosely correlated
-2.87%
GBIO - ARTV
39%
Loosely correlated
-2.61%
FATE - ARTV
39%
Loosely correlated
-0.07%
IPSC - ARTV
38%
Loosely correlated
+1.37%
RLYB - ARTV
37%
Loosely correlated
-5.17%
More

TNFA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNFA has been loosely correlated with ARTV. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if TNFA jumps, then ARTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNFA
1D Price
Change %
TNFA100%
-2.26%
ARTV - TNFA
47%
Loosely correlated
-3.80%
COGT - TNFA
39%
Loosely correlated
-1.44%
PHAT - TNFA
39%
Loosely correlated
+0.18%
TVGN - TNFA
36%
Loosely correlated
-1.18%
LRMR - TNFA
32%
Poorly correlated
+2.00%
More